Login to Your Account



Other News To Note


Tuesday, September 25, 2012
• Cannabis Science Inc., of Colorado Springs, Colo., said it started preclinical work in Europe for squamous/basal cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity using cannabinoids that have been demonstrated in recent studies to significant affect tumor necrosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription